http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TN-2018000263-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0597f9c318d2aeca86db94711c516383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60f67cf07e3fdc9c7d98b1c36039ec12
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-526
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-524
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
filingDate 2017-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_415ec87c7541ff04a9a7bd6f945467a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f5237b77eeeab60847aac1529dd415c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c830ebb5fbb406ce4c10584ae879319
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1787307155d068c3246b933ae796242f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb03e5eddc3d206c9fcc0ff01cffb0a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca315282b7b915af79bc280cc58e4993
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a56971dbb3bec248e9c7f3620b93047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e08beb7b9039a93b7b2a576596678425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a32656b86ef6d52986656553e1123d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40c3439f7de3cc7af8ad9e29173e4b41
publicationDate 2020-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TN-2018000263-A1
titleOfInvention BCMA and CD3 Bispecific T Cell Engaging Antibody Constructs
abstract The present invention provides bispecific antibody constructs of a specific Fc modality characterized by comprising a first domain binding to BCMA, a second domain binding to an extracellular epitope of the human and/or the Macaca CD3E chain and a third domain, which is the specific Fc modality. Moreover, the invention provides a polynucleotide, encoding the antibody construct, a vector comprising this polynucleotide, host cells, expressing the construct and a pharmaceutical composition comprising the same.
priorityDate 2016-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID127236
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415826292

Total number of triples: 47.